JRC News

  1. 4 Dec 2012

    From 3 to 5 December, the European Network of GMO Laboratories (ENGL) meets at the JRC Ispra site to discuss emerging issues related to GMO analysis but also celebrate its official 10th Anniversary.

  2. 8 Jan 2008

    The conference aims to address the science and technology underpinning GMO control and analysis by bringing together international experts willing to share knowledge and participate in promoting international scientific dialogue across diverse yet interdependent areas such as:

  3. 17 Nov 2015

    Members of the International Cooperation on Alternative Test Methods attended a two-day meeting hosted by the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM).

  4. 27 Nov 2014

    How can research in food and diets address how we will live and eat in 2050? By supporting the move towards individualised diets; by ensuring the sustainability of the future food system; by improving our understanding of links between food, nutrients and health; and by focusing on integrated policy-making. These are the main findings of a new foresight report that will support work done under Horizon 2020, the EU's Funding Programme for Research and Innovation for 2014-2020.

  5. 6 May 2011

    The JRC is hosting the Third International Conference on Alternatives for Developmental Neurotoxicity Testing (DNT3) on 10-13 May 2011 in Varese, Italy. The event brings together over 100 scientists and representatives from academia, industry and governmental organisations working on children's health, alternatives to animal testing and environmental protection.

  6. 21 Dec 2010

    The protection of animals used in scientific procedures such as safety testing of chemicals or cosmetics is of great concern to European citizens. Taking up this concern, the European Commission has launched several regulations that underline the European Union's commitment to improve animal welfare (e.g. Cosmetics Directive, REACH chemicals legislation) by promoting the use of alternatives to animal testing. A strong and continuous dialogue with key stakeholders in this area is recognised as pivotal for progress.

  7. 20 Oct 2015

    Novel, non-animal tools and scientific methodologies show high potential for the assessment of combined effects of chemicals on humans and the environment.

  8. 2 Mar 2009

    The European Commission’s independent Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) has published its opinion on the most recent developments in the risk assessment of nanomaterials. The opinion builds on and confirms earlier opinions published in 2006 and 2007. The JRC Institute for Health and Consumer Protection (IHCP) contributed to the opinion in the area of conceptual 'environment, health and safety' (EHS) aspects related the regulation of nanomaterials.

  9. 22 Oct 2009

    At this year's Annual Congress of the European Association of Nuclear Medicine (EANM 2009), the JRC's work in the field of alpha immunotherapy received special recognition. The presentation by Frank Bruchertseifer of the JRC Institute for Transuranium Elements (ITU) was nominated for the EANM 2009 Marie Curie Award and received the Eckert and Ziegler Award (Top 5 papers presented by young investigators below 38 years of age). The paper describes methods for the production of the alpha emitters Th-226 and Bi-213 and compares their therapeutic efficacy in vitro and in vivo.

  10. 22 Jul 2010

    Bisphenol A (BPA) is extensively used in the synthesis of plastics and resins, implying a widespread consumer exposure through various products coming in contact with food, such as baby bottles or food cans. Despite several risk assessment studies performed over the last ten years by different regulatory bodies worldwide, there is so far no agreement about the impact of BPA on human health. The review report "Bisphenol A and baby bottles: challenges and perspectives", published by the JRC Institute for Health and Consumer Protection (IHCP), provides an overview of the issues at the base of the on-going debate and highlights some areas of uncertainty, which may be the subject of future investigations.